Fjarde Ap Fonden Zimmer Biomet Holdings, Inc. Transaction History

Fjarde Ap Fonden

$8.34 Billion
Q1 2025

A detailed history of Fjarde Ap Fonden transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 24,347 shares of ZBH stock, worth $2.31 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

24,347

Previous 34,447 29.32%

Holding current value

$2.31 Million

Previous $3.64 Million 24.26%

% of portfolio

0.03%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$98.98 - $113.18 $999,698 - $1.14 Million	-10,100 Reduced 29.32%	24,347 $2.76 Million
Q4 2024 Feb 04, 2025	BUY	$101.77 - $113.02 $508,850 - $565,100	5,000 Added 16.98%	34,447 $3.64 Million
Q3 2024 Nov 08, 2024	SELL	$104.47 - $116.17 $470,115 - $522,765	-4,500 Reduced 13.26%	29,447 $3.18 Million
Q1 2024 Apr 25, 2024	SELL	$119.98 - $132.61 $59,990 - $66,305	-500 Reduced 1.45%	33,947 $4.48 Million
Q4 2023 Feb 14, 2024	SELL	$102.72 - $121.7 $623,407 - $738,597	-6,069 Reduced 14.98%	34,447 $4.19 Million
Q3 2023 Oct 23, 2023	BUY	$110.76 - $143.18 $243,672 - $314,996	2,200 Added 5.74%	40,516 $4.55 Million
Q2 2023 Aug 02, 2023	SELL	$126.43 - $145.6 $758,580 - $873,600	-6,000 Reduced 13.54%	38,316 $5.58 Million
Q1 2023 May 15, 2023	SELL	$121.91 - $130.94 $975,280 - $1.05 Million	-8,000 Reduced 15.29%	44,316 $5.73 Million
Q4 2022 Feb 14, 2023	SELL	$104.7 - $128.4 $523,500 - $642,000	-5,000 Reduced 8.72%	52,316 $6.67 Million
Q2 2022 Aug 11, 2022	SELL	$102.23 - $133.85 $194,237 - $254,315	-1,900 Reduced 3.21%	57,316 $6.02 Million
Q1 2022 May 13, 2022	SELL	$108.42 - $129.58 $1.13 Million - $1.35 Million	-10,400 Reduced 14.94%	59,216 $7.57 Million
Q4 2021 Feb 15, 2022	BUY	$115.43 - $146.63 $80,801 - $102,641	700 Added 1.02%	69,616 $8.84 Million
Q3 2021 Nov 15, 2021	SELL	$136.35 - $158.76 $354,510 - $412,776	-2,600 Reduced 3.64%	68,916 $10.1 Million
Q2 2021 Aug 12, 2021	BUY	$152.95 - $173.41 $76,475 - $86,705	500 Added 0.7%	71,516 $11.5 Million
Q1 2021 May 17, 2021	BUY	$148.16 - $159.71 $133,344 - $143,739	900 Added 1.28%	71,016 $11.4 Million
Q4 2020 Feb 12, 2021	BUY	$128.25 - $151.41 $731,025 - $863,037	5,700 Added 8.85%	70,116 $10.8 Million
Q3 2020 Nov 13, 2020	BUY	$113.59 - $141.68 $318,052 - $396,704	2,800 Added 4.54%	64,416 $8.77 Million
Q2 2020 Aug 13, 2020	BUY	$87.02 - $133.4 $202,756 - $310,822	2,330 Added 3.93%	61,616 $7.35 Million
Q1 2020 May 11, 2020	SELL	$78.28 - $155.73 $320,948 - $638,493	-4,100 Reduced 6.47%	59,286 $5.99 Million
Q4 2019 Feb 10, 2020	BUY	$127.4 - $146.83 $586,040 - $675,418	4,600 Added 7.82%	63,386 $9.49 Million
Q3 2019 Oct 31, 2019	BUY	$113.33 - $138.46 $226,660 - $276,920	2,000 Added 3.52%	58,786 $8.07 Million
Q2 2019 Jul 17, 2019	SELL	$108.87 - $125.09 $631,446 - $725,522	-5,800 Reduced 9.27%	56,786 $6.69 Million
Q1 2019 Apr 29, 2019	BUY	$97.5 - $125.79 $1.3 Million - $1.68 Million	13,353 Added 27.12%	62,586 $7.99 Million
Q4 2018 Jan 31, 2019	SELL	$94.4 - $126.76 $604,160 - $811,264	-6,400 Reduced 11.5%	49,233 $5.11 Million
Q3 2018 Nov 09, 2018	SELL	$108.41 - $127.64 $281,866 - $331,864	-2,600 Reduced 4.46%	55,633 $7.31 Million
Q2 2018 Jul 12, 2018	SELL	$102.12 - $114.04 $64,948 - $72,529	-636 Reduced 1.08%	58,233 $6.49 Million
Q1 2018 May 07, 2018	BUY	$104.31 - $124.46 $3,442 - $4,107	33 Added 0.06%	58,869 $6.42 Million
Q4 2017 Feb 12, 2018	BUY	$105.55 - $120.83 $948,155 - $1.09 Million	8,983 Added 18.02%	58,836 $7.1 Million
Q3 2017 Nov 07, 2017	BUY	$106.92 - $117.79 $280,023 - $308,492	2,619 Added 5.54%	49,853 $5.84 Million
Q2 2017 Aug 08, 2017	BUY	N/A	47,234	47,234 $6.07 Million

Others Institutions Holding ZBH

# of Institutions

1,119

Shares Held

185M

Call Options Held

577K

Put Options Held

314K

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $19.9B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account